Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma

Karen J Mylam; Tarec Christoffer El-Galaly; Martin Hutchings; Peter Brown; Bodil Himmelstrup; Oke Gerke; Dorte Gillstrøm; Ida Blok Sillesen; Lars Munksgaard; Bjarne B Pedersen; Ilse Christiansen; Paw Jensen; Anne Louise Nielsen; Lars M Pedersen

doi:10.3109/10428194.2013.850165

Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma

Karen J Mylam, Tarec Christoffer El-Galaly, Martin Hutchings, Peter Brown, Bodil Himmelstrup, Oke Gerke, Dorte Gillstrøm, Ida Blok Sillesen, Lars Munksgaard, Bjarne B Pedersen, Ilse Christiansen, Paw Jensen, Anne Louise Nielsen, Lars M Pedersen

8 Citationer (Scopus)

Abstract

The aim of this study was to evaluate the prognostic value of clinician interpretation of positron emission tomography/computed tomography (PET/CT) reports at mid-therapy, interim PET (I-PET) and after the end of first-line therapy (E-PET) in patients with diffuse large B-cell lymphoma (DLBCL). Four hundred and thirty patients were enrolled in this study comprising a total of 617 PET reports. Each report was evaluated by three expert hematologists randomly selected from a panel of nine. Reports were labeled positive or negative if all three interpreters agreed. All others were considered indeterminate. Indeterminate reports accounted for 59% of I-PET and 49% of E-PET reports. Two-year overall survival (OS) for patients with a positive, indeterminate and negative I-PET was 58%, 87% and 89% (p

Originalsprog	Engelsk
Tidsskrift	Leukemia and Lymphoma
Vol/bind	55
Udgave nummer	7
Sider (fra-til)	1563-69
ISSN	1042-8194
DOI	https://doi.org/10.3109/10428194.2013.850165
Status	Udgivet - 2014

Adgang til dokumentet

10.3109/10428194.2013.850165

Fingeraftryk

Dyk ned i forskningsemnerne om 'Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma'. Sammen danner de et unikt fingeraftryk.

Citationsformater

Mylam, K. J., El-Galaly, T. C., Hutchings, M., Brown, P., Himmelstrup, B., Gerke, O., Gillstrøm, D., Sillesen, I. B., Munksgaard, L., Pedersen, B. B., Christiansen, I., Jensen, P., Nielsen, A. L., & Pedersen, L. M. (2014). Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma. Leukemia and Lymphoma, 55(7), 1563-69. https://doi.org/10.3109/10428194.2013.850165

Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma. / Mylam, Karen J; El-Galaly, Tarec Christoffer; Hutchings, Martin et al.
I: Leukemia and Lymphoma, Bind 55, Nr. 7, 2014, s. 1563-69.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Mylam, KJ, El-Galaly, TC, Hutchings, M , Brown, P, Himmelstrup, B, Gerke, O, Gillstrøm, D, Sillesen, IB, Munksgaard, L, Pedersen, BB, Christiansen, I, Jensen, P, Nielsen, AL & Pedersen, LM 2014, 'Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma', Leukemia and Lymphoma, bind 55, nr. 7, s. 1563-69. https://doi.org/10.3109/10428194.2013.850165

@article{78e0156f635d41789cf753497b0af69d,

title = "Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma",

abstract = "The aim of this study was to evaluate the prognostic value of clinician interpretation of positron emission tomography/computed tomography (PET/CT) reports at mid-therapy, interim PET (I-PET) and after the end of first-line therapy (E-PET) in patients with diffuse large B-cell lymphoma (DLBCL). Four hundred and thirty patients were enrolled in this study comprising a total of 617 PET reports. Each report was evaluated by three expert hematologists randomly selected from a panel of nine. Reports were labeled positive or negative if all three interpreters agreed. All others were considered indeterminate. Indeterminate reports accounted for 59% of I-PET and 49% of E-PET reports. Two-year overall survival (OS) for patients with a positive, indeterminate and negative I-PET was 58%, 87% and 89% (p ",

author = "Mylam, {Karen J} and El-Galaly, {Tarec Christoffer} and Martin Hutchings and Peter Brown and Bodil Himmelstrup and Oke Gerke and Dorte Gillstr{\o}m and Sillesen, {Ida Blok} and Lars Munksgaard and Pedersen, {Bjarne B} and Ilse Christiansen and Paw Jensen and Nielsen, {Anne Louise} and Pedersen, {Lars M}",

year = "2014",

doi = "10.3109/10428194.2013.850165",

language = "English",

volume = "55",

pages = "1563--69",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "7",

}

TY - JOUR

T1 - Prognostic impact of clinician-based interpretation of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography reports obtained in patients with newly diagnosed diffuse large B-cell lymphoma

AU - Mylam, Karen J

AU - El-Galaly, Tarec Christoffer

AU - Hutchings, Martin

AU - Brown, Peter

AU - Himmelstrup, Bodil

AU - Gerke, Oke

AU - Gillstrøm, Dorte

AU - Sillesen, Ida Blok

AU - Munksgaard, Lars

AU - Pedersen, Bjarne B

AU - Christiansen, Ilse

AU - Jensen, Paw

AU - Nielsen, Anne Louise

AU - Pedersen, Lars M

PY - 2014

Y1 - 2014

N2 - The aim of this study was to evaluate the prognostic value of clinician interpretation of positron emission tomography/computed tomography (PET/CT) reports at mid-therapy, interim PET (I-PET) and after the end of first-line therapy (E-PET) in patients with diffuse large B-cell lymphoma (DLBCL). Four hundred and thirty patients were enrolled in this study comprising a total of 617 PET reports. Each report was evaluated by three expert hematologists randomly selected from a panel of nine. Reports were labeled positive or negative if all three interpreters agreed. All others were considered indeterminate. Indeterminate reports accounted for 59% of I-PET and 49% of E-PET reports. Two-year overall survival (OS) for patients with a positive, indeterminate and negative I-PET was 58%, 87% and 89% (p

AB - The aim of this study was to evaluate the prognostic value of clinician interpretation of positron emission tomography/computed tomography (PET/CT) reports at mid-therapy, interim PET (I-PET) and after the end of first-line therapy (E-PET) in patients with diffuse large B-cell lymphoma (DLBCL). Four hundred and thirty patients were enrolled in this study comprising a total of 617 PET reports. Each report was evaluated by three expert hematologists randomly selected from a panel of nine. Reports were labeled positive or negative if all three interpreters agreed. All others were considered indeterminate. Indeterminate reports accounted for 59% of I-PET and 49% of E-PET reports. Two-year overall survival (OS) for patients with a positive, indeterminate and negative I-PET was 58%, 87% and 89% (p

U2 - 10.3109/10428194.2013.850165

DO - 10.3109/10428194.2013.850165

M3 - Journal article

C2 - 24144339

SN - 1042-8194

VL - 55

SP - 1563

EP - 1569

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 7

ER -